Madison Grinnell

Madison Grinnell

Auto-generated profile, based on publicly available information

Madison Grinnell

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in International Journal of Women's Dermatology
Verified
Journal Article
Open access
MLMarissa Lobl
Marissa Lobl
MGMadison Grinnell
Madison Grinnell
SHShauna Higgins
Shauna Higgins
KYKelli Yost
Kelli Yost
PGPearl Grimes
Pearl Grimes
AWAshley Wysong
Ashley Wysong
Despite a substantial increase in the number of women matriculating into medical school, a gender gap still exists with respect to academic leadership positions. This gap is apparent in the field of dermatology, particularly in the composition of dermatology journal editorial boards. To address this gap, we must first acknowledge its existence, examine potential reasons for its existence, and propose strategies to narrow the gap. Our objective is to determine the representation of women as editors in dermatology journals. A comprehensive search was performed for dermatology journals indexed in Medline, Journal Citation Reports, Scopus, and Embase in August, September, and October 2018. The editorial board of each journal was analyzed for the number and percentage of male and female editors in four different positions. We verified the accuracy of editorial boards listed on publisher websites by emailing administrative personnel. We also recorded the number of years from terminal degree for editorial board members of the 10 journals with the highest impact factors using SCImago Journal Rankings. Women occupied 18% of editor-in-chief positions, 36% of deputy editor roles, 22% of overall editorial board positions, and 22% of other board roles. The average number of years since terminal degree was not statistically different between women and men, with women averaging 30.2 years and men averaging 28.0 years since completion of terminal degree (p = .27). Our findings suggest that women are underrepresented as editors at all levels in dermatology journals. This supports prior findings reporting a minority of women in academic leadership roles. Thus, although women have made major advancements in the medical field over the past century, there remains room for progress with regard to equal representation in academic leadership roles, including editorial positions, professorships, and department chair roles.

1 September 2022 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
JPJay Patel
Jay Patel
TVThomas Vazquez
Thomas Vazquez
FCFelix Chin
Felix Chin
EKEmily Keyes
Emily Keyes
DYDaisy Yan
Daisy Yan
VWVictoria P WERTH
Victoria P WERTH

1 January 2020 in International Journal of Women's Dermatology
Verified
Journal Article
Open access
MGMadison Grinnell
Madison Grinnell
SHShauna Higgins
Shauna Higgins
KYKelli Yost
Kelli Yost
OOOlivia Ochuba
Olivia Ochuba
MLMarissa Lobl
Marissa Lobl
AWAshley Wysong
Ashley Wysong
Historically, women have been underrepresented in leadership positions in medicine. The reasons for this are multifactorial. In recent years, women's representation in medicine has improved. However, inequities in the proportion of men and women in medical leadership remain, especially with regard to editorial journal boards. This study aimed to explore current trends of women in leadership positions on journal editorial boards. A comprehensive search for women's health journals was performed in collaboration with university librarians in February 2019 using EMBASE, Scopus, SciFinder, and MEDLINE records for journals with relevance to women's health. Each journal was e-mailed to verify the accuracy of the journal editorial boards listed on their respective webpages. Five categories, as well as the totals for each journal, were analyzed for the proportion of women versus men: editor-in-chief, associate editor, deputy editor, and section editor, and other. Women comprised the minority of positions on women's health editorial boards. Of the total 1440 board members included, 602 members (42%) were women and 838 members (58%) were men. Women occupied 54 of 132 editor-in-chief positions (41%), 257 of 596 associate editor positions (43%), 13 of 42 deputy editor positions (30%), 46 of 120 section editor positions (38%), and 232 of 549 other editor positions (42%). Although the sex gap in leadership in medicine is improving, it is still present. Our findings suggest that women are underrepresented as editors at most levels in women's health journals centered on topics such as reproductive health, obstetrics and gynecology, perinatology, gynecological oncology, and breastfeeding. With sponsorship/mentorship for women, flexible scheduling, and considerate thought in leadership appointment, this sex gap will continue to improve.

10 December 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TVThomas Vazquez
Thomas Vazquez
JPJay Patel
Jay Patel
NKNilesh Kodali
Nilesh Kodali
DDDeAnna Diaz
DeAnna Diaz
MBMuhammad M. Bashir
Muhammad M. Bashir
VWVictoria P WERTH
Victoria P WERTH

4 January 2022 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
SMSpandana Maddukuri
Spandana Maddukuri
JPJay Patel
Jay Patel
DDDe Anna Diaz
De Anna Diaz
KCKristen L. Chen
Kristen L. Chen
MWMaria Wysocka
Maria Wysocka
VWVictoria P WERTH
Victoria P WERTH
Background: Lenabasum is a cannabinoid type 2 receptor (CB2R) reverse agonist that demonstrates anti-inflammatory effects in vivo and in vitro in dermatomyositis (DM) and is currently being investigated for therapeutic potential. The purpose of our study is to investigate CB2R distribution as well as the effects of lenabasum in DM. Methods: Immunohistochemistry staining (IHC) was utilized to examine immune cell and cytokine production changes in lesional DM skin biopsies from lenabasum and placebo-treated patients. CB2R expression in various immune cell populations within DM skin was investigated with image mass cytometry (IMC), whereas flow cytometry elucidated CB2R expression in DM peripheral blood mononuclear cells (PBMCs) as well as cytokine production by CB2R-expressing cell populations. Results: After 12 weeks of lenabasum treatment, IHC staining showed that CD4+ T cells, CB2R, IL-31, IFN-γ, and IFN-β cytokines were downregulated. IFN-γ and IFN-β mRNA decreased in lesional DM skin but not in PBMCs. IMC findings revealed that CB2R was upregulated in DM lesional skin compared to HC skin and DM PBMCs (p<0.05). In DM skin, CB2R was upregulated on dendritic cells, B cells, T cells, and macrophages while dendritic cells had the greatest expression in both DM skin and PBMCs (p<0.05). These CB2R+ cells in the skin produce IL-31, IL-4, IFN-γ, and IFN-β. Conclusion: Our findings of differential CB2R expression based on location and cell type suggest modes by which lenabasum may exert anti-inflammatory effects in DM and highlights dendritic cells as potential therapeutic targets.